How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

18+ Only. Restrictions and eligibility requirements apply. Not available in all jurisdictions. Trading is risky. 100% loss can occur. See https://polymarket.com/tos ...

AI is moving at a breakneck pace, and frankly, it’s hard to keep up. Sure, it’s cool to have a chatbot that acts like it has a Ph.D. in everything, but the reality is a lot messier. You can’t turn ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

New Genshin Impact codes can provide you with free Primogems, Mora, Hero's Wit, Adventurer's Experience, and more, with some available this available in October 2026. There are some semi-permanent ...

Recent insider activity at Recursion Pharmaceuticals included 2 transactions totaling $97,222.74. One was a tax payment of $18,400.36 and the other was a sale of $78,822.38. Average transaction ...

View the basic RXRX option chain and compare options of Recursion Pharmaceuticals, Inc. on Yahoo Finance.